1245735-33-4

Basic information

• Product Name: methyl 2-benzoyl-5-(5-((4-chlorophenyl)(methyl)amino)pyridine-2-carbonyl)benzoate
• Synonyms: methyl 2-benzoyl-5-(5-((4-chlorophenyl)(methyl)amino)pyridine-2-carbonyl)benzoate
• CAS NO: 1245735-33-4
• Molecular Weight: 484.939
• Mol File: 1245735-33-4.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: methyl 2-benzoyl-5-(5-((4-chlorophenyl)(methyl)amino)pyridine-2-carbonyl)benzoate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 2-benzoyl-5-(5-((4-chlorophenyl)(methyl)amino)pyridine-2-carbonyl)benzoate(1245735-33-4)
• EPA Substance Registry System: methyl 2-benzoyl-5-(5-((4-chlorophenyl)(methyl)amino)pyridine-2-carbonyl)benzoate(1245735-33-4)

Safety Data

• Hazardous Substances Data: 1245735-33-4(Hazardous Substances Data)

Upstream product

• 1286755-47-2 5-{5-[(4-chlorophenyl)(methyl)amino]picolinoyl}-2-trimethylstannanylbenzoic acid methyl ester 
• 1711-05-3 m-anisoyl chloride 
• 718620-09-8 5-bromo-2-(phenylcarbonyl)benzoic acid 
• 100-52-7 benzaldehyde 
• 31181-90-5 5-bromo-pyridine-2-carbaldehyde 
• 932-96-7 N-methyl(p-chloroaniline) 
• 1244043-46-6 5-((4-chlorophenyl)(methyl)amino)pyridine-2-carbaldehyde 
• 1245735-30-1 2-benzoyl-5-iodobenzoic acid methyl ester 
• 181765-86-6 5-bromo-2-iodo-benzoic acid methyl ester 
• 1245735-31-2 2-benzoyl-5-[(5-bromo-2-pyridyl)hydroxymethyl]benzoic acid methyl ester 
• 1245735-32-3 2-benzoyl-5-(5-bromopicolinoyl)benzoic acid methyl ester 

Downstream Products

• 1245734-57-9 2-benzoyl-5-(5-((4-chlorophenyl)(methyl)amino)pyridine-2-carbonyl)benzoic acid 

Relevant articles and documents

Tandem benzophenone amino pyridines, potent and selective inhibitors of human leukotriene C4 synthase

Cysteinyl leukotrienes (cys-LTs) are lipid mediators of inflammation. The enzyme catalyzing synthesis of cys-LTs, leukotriene C4 synthase (LTC4S), is considered an important drug target. Here we report the synthesis and characterization of thre

BIS AROMATIC COMPOUNDS FOR USE AS LTC4 SYNTHASE INHIBITORS

There is provided compounds of formula (I): wherein E1, E2a, E2b, E2c, E4, D1, D2, D3, L1, Y1, L2 and Y2 have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of leukotriene C4 synthase is desired and/or required, and particularly in the treatment of a respiratory disorder and/or inflammation.